Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,699Revenue (TTM) $M1,399Net Margin (%)25.5Altman Z-Score4.0
Enterprise Value $M7,962EPS (TTM) $5.7Operating Margin %37.8Piotroski F-Score8
P/E(ttm)22.3Beneish M-Score-2.6Pre-tax Margin (%)34.3Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %--Quick Ratio5.3Cash flow > EarningsY
Price/Sales5.75-y EBITDA Growth Rate %36.9Current Ratio5.4Lower Leverage y-yY
Price/Free Cash Flow20.2y-y EBITDA Growth Rate %10.9ROA % (ttm)10.4Higher Current Ratio y-yN
Dividend Yield %--PEG0.6ROE % (ttm)22.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M60.5ROIC % (ttm)21.0Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JAZZJoel Greenblatt 2016-06-30 Reduce-0.14%$130.55 - $157.16
($147.16)
$ 127.19-14%Reduce -46.66%105,404
JAZZGeorge Soros 2016-06-30 Buy 0.03%$130.55 - $157.16
($147.16)
$ 127.19-14%New holding7,800
JAZZKen Fisher 2016-06-30 Reduce$130.55 - $157.16
($147.16)
$ 127.19-14%Reduce -4.62%1,859
JAZZJoel Greenblatt 2016-03-31 Add0.02%$112.72 - $140.56
($124.56)
$ 127.192%Add 6.84%197,619
JAZZGeorge Soros 2016-03-31 Sold Out -0.01%$112.72 - $140.56
($124.56)
$ 127.192%Sold Out0
JAZZKen Fisher 2016-03-31 Add$112.72 - $140.56
($124.56)
$ 127.192%Add 4.84%1,949
JAZZNWQ Managers 2015-12-31 Sold Out -0.25%$121.94 - $150.45
($138.92)
$ 127.19-8%Sold Out0
JAZZJoel Greenblatt 2015-12-31 Add0.24%$121.94 - $150.45
($138.92)
$ 127.19-8%Add 620.48%184,961
JAZZGeorge Soros 2015-12-31 Buy 0.01%$121.94 - $150.45
($138.92)
$ 127.19-8%New holding3,200
JAZZKen Fisher 2015-12-31 Add$121.94 - $150.45
($138.67)
$ 127.19-8%Add 7.77%1,859
JAZZJoel Greenblatt 2015-09-30 Add0.03%$124.46 - $193.02
($172.53)
$ 127.19-26%Add 620.11%25,672
JAZZNWQ Managers 2015-09-30 Reduce-0.01%$124.46 - $193.02
($172.53)
$ 127.19-26%Reduce -2.34%123,720
JAZZKen Fisher 2015-09-30 Add$124.46 - $193.02
($172.53)
$ 127.19-26%Add 32.69%1,725
JAZZSteve Mandel 2015-06-30 Sold Out -0.17%$167.87 - $189.92
($179.49)
$ 127.19-29%Sold Out0
JAZZNWQ Managers 2015-06-30 Add0.15%$167.87 - $189.92
($179.49)
$ 127.19-29%Add 95.42%126,680
JAZZJoel Greenblatt 2015-06-30 Reduce-0.01%$167.87 - $189.92
($179.49)
$ 127.19-29%Reduce -67.22%3,565
JAZZSteve Mandel 2015-03-31 Reduce-1.12%$158.12 - $189.01
($171.62)
$ 127.19-26%Reduce -86.14%260,985
JAZZJoel Greenblatt 2015-03-31 Buy 0.01%$158.12 - $189.01
($171.62)
$ 127.19-26%New holding10,874
JAZZNWQ Managers 2015-03-31 Add$158.12 - $189.01
($171.62)
$ 127.19-26%Add 0.06%64,824
JAZZKen Fisher 2015-03-31 Buy $158.12 - $189.01
($171.62)
$ 127.19-26%New holding1,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JAZZ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MILLER MICHAEL PATRICKSVP, US Commercial 2016-09-19Sell200$126.170.81view
Mulligan SeamusDirector 2016-08-25Sell27,968$128.32-0.88view
Treacy PaulSVP, Technical Operations 2016-08-16Sell1,292$137.47-7.48view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-08-15Sell100$136.45-6.79view
Winningham Rick EDirector 2016-08-15Sell633$136.45-6.79view
Sohn Catherine A.Director 2016-08-15Sell633$136.45-6.79view
RIEDEL NORBERT GDirector 2016-08-15Sell633$136.45-6.79view
McSharry Heather AnnDirector 2016-08-15Sell685$136.45-6.79view
ENRIGHT PATRICK GDirector 2016-08-15Sell633$136.45-6.79view
BERNS PAUL LDirector 2016-08-15Sell633$136.45-6.79view

Quarterly/Annual Reports about JAZZ:

News about JAZZ:

Articles On GuruFocus.com
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 
Stocks Fisher Investments Has Bought for Past 2 Quarters May 03 2016 
Citigroup, Amgen Are Trading With Wide Margin of Safety Mar 30 2016 
Weekly Insider Sells Highlight: MHK, JAZZ, BMY, ZAYO Mar 23 2015 
Pharmaceutical Giant Merck Buys Cubist Pharma Dec 09 2014 
Growth Momentum Should Continue For This Pharmaceutical Company Nov 15 2014 
Jazz Pharmaceuticals: Growth Trajectory Can Continue In Future Sep 03 2014 
Weekly CFO Sells Highlight: Google Inc, Jazz Pharmaceuticals PLC, Jack in the Box Inc. Jun 30 2014 
Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
Weekly CFO Sells Highlight: Jazz Pharmaceuticals PLC, Carnival PLC, Juniper Networks Inc., Home Depo Mar 10 2014 

More From Other Websites
Next Year Setting Up To Be Smooth For Jazz Pharmaceuticals Sep 21 2016
How Analysts See Horizon Compared to Its Peers Sep 21 2016
Understanding Valeant’s Improved Valuation Multiple Sep 19 2016
Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference Sep 17 2016
Halvorsen Bought 13 New Holdings in 2nd Quarter Sep 08 2016
Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference Sep 07 2016
Jazz Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference Sep 07 2016
3 Hottest Cancer Biotech Acquisition Targets After Medivation Sep 06 2016
Weakness Seen in Jazz Pharmaceuticals (JAZZ) Estimates: Should You Stay Away? Aug 29 2016
Here Are All The Big Biotech Mergers In 2016 Aug 27 2016
Hedge Funds Are Obesely Overweight These 5 Mid-caps Aug 26 2016
Janney Initiates Jazz Pharma At Neutral, Cites Potential Competition For 'Blockbuster Narcolepsy... Aug 25 2016
ETF’s with exposure to Jazz Pharmaceuticals Plc : August 24, 2016 Aug 24 2016
Pfizer’s Medivation Acquisition: What You Need to Know Aug 23 2016
JAZZ PHARMACEUTICALS PLC Financials Aug 18 2016
ETF’s with exposure to Jazz Pharmaceuticals Plc : August 12, 2016 Aug 12 2016
Why This Analyst Sees Huge Upside for Valeant and 2 More Specialty Pharmas Aug 12 2016
Jazz Pharmaceuticals Remains A Buy At Deutsche Bank Post Q2 Report Aug 11 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)